When was Sagimet Biosciences founded?

Sagimet Biosciences was founded in 2007 and raised its 1st funding round within a year of its incorporation.

Where is Sagimet Biosciences located?

Sagimet Biosciences is headquartered in San Mateo, United States.

Is Sagimet Biosciences a funded company?

Sagimet Biosciences is a funded company, having raised a total of $215M across 9 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on May 22, 2007.

When was the latest funding round of Sagimet Biosciences?

Sagimet Biosciences' latest funding was a $***** Series F round on Dec 21, 2020, with participation from 8 investors. Its primary sector is Diversified Pharmaceuticals. In United States, the Diversified Pharmaceuticals sector has seen $585M in funding in 2026 to date.

What is the annual revenue of Sagimet Biosciences?

Annual revenue of Sagimet Biosciences is between $1M and $10M as on Dec 31, 2023

Sagimet Biosciences - 2026 Company Profile, Funding & Financials

Company Details

Developer of inhibitor-based drugs for treating cancer and dysfunctional metabolic diseases. It developing novel therapeutics to treat important diseases such as non-alcoholic steatohepatitis (NASH), acne, and certain cancers.

Website: sagimet.com
Email ID: *****@sagimet.com
Phone Number: +1 **********

Key Metrics

Founded Year

2007

Location

San Mateo, United States

Stage

Public

Total Funding

$215M in 9 rounds

Latest Funding Round

Series F, Dec 21, 2020, $*****

Investors

New Enterprise Associates & 9 more

Annual Revenue

$1M - $10M as on Dec 31, 2023

Exit Details

Public

View Sagimet Biosciences' full profile

Sagimet Biosciences is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Sagimet Biosciences Inc. CIN: 4272784 , United States, Active	Dec 18, 2006	$1M - $10M (As on Dec 31, 2023)	10 (As on Dec 31, 2023)	-

Sagimet Biosciences got listed on Jul 14, 2023.

Click here to take a look at Sagimet Biosciences's IPO in detail

Sagimet Biosciences has raised a total funding of $215M over 9 rounds. Its first funding round was on May 22, 2007. Its latest funding round was a Series F round on Dec 21, 2020 for $*****. 8 investors participated in its latest round. Sagimet Biosciences has 10 institutional investors.

Here is the list of recent funding rounds of Sagimet Biosciences:

Filter this list

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
Dec 21, 2020	1218380	Series F	5146304	9942130	2872056	2254020
Aug 05, 2019	2222864	Series E	3795518	8569425	2542025	Kleiner Perkins & 1 more
Feb 2019	9409451	Series E	9438681	3377629	Ascletis	3846236